OneMedNet Corp
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
ONMD$5.82-3.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Deficit
(In thousands, except share data)
| Additional · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · Treasury Stock · Paid-in · Accumulated · Stockholders’ | ||||||||
| Shares · Amount · Shares · Amount · Capital · Deficit · Deficit | ||||||||
| Balances as of December 31, 2023 | 23,572,232 | $2 | - | $ | - | $77,996 | $(91,440) | $(13,442) |
| Issuance of common stock to settle deferred underwriter fee payable | 277,778 | - | - | - | 242 | - | 242 | |
| Repurchase of common stock | - | - | (187,745) | (529) | - | - | (529) | |
| Vesting of restricted stock units | 200,000 | - | - | - | - | - | - | |
| Issuance of common stock and pre-funded warrants in connection with private placements, net of issuance costs | 3,598,850 | - | - | - | 6,270 | - | 6,270 | |
| Issuance of common stock to settle Yorkville commitment fee | 526,312 | - | - | - | 500 | - | 500 | |
| Issuance of warrants to terminate Helena SPA | - | - | - | - | 35 | - | 35 | |
| Extinguishment of officer accrued salaries | - | - | - | - | 132 | - | 132 | |
| Partial conversion of Yorkville Note | - | - | - | - | 343 | - | 343 | |
| Stock-based compensation expense | - | - | - | - | 628 | - | 628 | |
| Net loss | - | - | - | - | - | (10,129) | (10,129) | |
| Balances as of December 31, 2024 | 28,175,172 | $2 | (187,745) | $(529) | $86,146 | $(101,569) | $(15,950) | |
| Issuance of common stock in connection with private placements, net of issuance costs | 4,864,619 | - | - | - | 2,497 | - | 2,497 | |
| Issuance of common stock upon partial conversions of Yorkville Note | 1,866,562 | - | - | - | 1,392 | - | 1,392 | |
| Issuance of common stock in connection with settlement of vendor payable | 250,000 | - | - | - | 111 | - | 111 | |
| Issuance of common stock upon conversions of loans with related parties | 3,166,475 | - | - | - | 2,334 | - | 2,334 | |
| Issuance of common stock upon conversions of PIPE Notes | 1,453,174 | - | - | - | 510 | - | 510 | |
| Issuance of common stock upon conversions of loan extensions with related parties | 3,650,248 | - | - | - | 2,584 | - | 2,584 | |
| Issuance of common stock in connection with subscription agreements with related parties | 3,438,538 | - | - | - | 1,697 | - | 1,697 | |
| Issuance of common stock in connection with exercises of pre-funded warrants | 3,048,232 | - | - | - | - | - | - | |
| Issuance of common stock in connection with exercises of Helena Termination Warrants | 50,000 | - | - | - | 60 | - | 60 | |
| Issuance of common stock in connection with Yorkville SEPA | 1,020,880 | - | - | - | 2,569 | - | 2,569 | |
| Issuance of common stock for consulting services rendered | 30,000 | - | - | - | 70 | - | 70 | |
| Vesting of restricted stock units | 970,574 | - | - | - | - | - | - | |
| Stock-based compensation expense | - | - | - | - | 1,962 | - | 1,962 | |
| Net loss | - | - | - | - | - | (2,801) | (2,801) | |
| Balances as of December 31, 2025 | 51,984,474 | $2 | (187,745) | $(529) | $101,932 | $(104,370) | $(2,965) | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.